In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone
- 31 March 2004
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 88 (3), 277-288
- https://doi.org/10.1016/j.jsbmb.2003.12.004
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical Pharmacokinetics of MifepristoneClinical Pharmacokinetics, 1997
- Antiprogestins: Mechanism of Action and ContraceptiveAnnual Review of Pharmacology and Toxicology, 1996
- Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant womenContraception, 1993
- The steroid antagonist RU38486 is metabolized by the liver microsomal P450 mono-oxygenasesBiochemical and Biophysical Research Communications, 1990
- Screening of anti-progestagens by receptor studies and bioassaysJournal of Steroid Biochemistry, 1988
- Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genesExperimental Cell Research, 1987
- Plasma concentrations and receptor binding of RU 486 and its metabolites in humansThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoidsThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- New steroids with antiprogestational and antiglucocorticoid activitiesSteroids, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976